Investor Presentation March 2023

Internal Investments to Drive Organic Growth and Improve Animal Welfare Increased internal capacity and upgraded facilities in response to strong demand and to support animal welfare Capital investments of ~$78 million from FY 2018 through FY 2022 > - Evansville, IN — annual capacity expanded from ~$13 million to ~$50 million Fort Collins, CO - infrastructure, equipment and facility upgrades; annual capacity has increased from ~$5 million to ~$15 million since acquisition Gaithersburg, MD – infrastructure, equipment and facility upgrades; annual capacity has increased from ~$7 million to ~$25 million since acquisition St. Louis, MO – Phased expansion project completed Jan. 2022 Boulder, CO - infrastructure, equipment and facility upgrades to provide additional 30% capacity (completed in Q1 FY 2023) Capital investments of ~$8.4 million in Q1 FY 23 has been invested > US & Europe - investment in upgrading & expanding certain facilities to add capacity and implement planned and proposed site optimizations and enhance animal welfare (ongoing) Morrisville, NC - infrastructure, equipment and facility upgrades to expand capacity by 30% (completed in Q1 FY 2023) Rockville, MD - buildout of newly leased 48,000 sq foot facility to support biotherapeutics and genetic toxicology growth (expected to be completed by end of Q2 FY 2023) Fort Collins, CO - expanding operations by approximately 50% revenue run rate capacity (expected to be completed by end of FY 2023) Inotiv's Expanded Evansville Facility Inotiv's New St. Louis Laboratories WASTE MACS Quant 14

View entire presentation